Scientific publications

DRP® related publications


Vangsted, A.J. et al.
Drug response prediction in high-risk multiple myeloma
Gene 644 (2018) 80-86

Kappel Buhl, I. et al.
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
PloS One 2018; 10.1371


Kappel Buhl, A. et al.
Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort
Abstract no.: 1071, ASCO Annual Meeting, Chicago, 2017


Kappel Buhl, I. et al.
Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer
Abstract no.: e20007, ASCO Annual Meeting, Chicago, 2016

Dreier Christensen, D. et al.
Fulvestrant response prediction from transcriptome data obtained from primary breast cancer biopsies
Abstract no.: e12056, ASCO Annual Meeting, Chicago, 2016

Kappel Buhl, I. et al. 
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
PLoS One. 2016; 11(5): e0155123 

Winther, M. et al.
Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophagual Cancer
PLoS One. 2016; 11(2): e0148070


Knudsen, S. et al.
Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL 

PLoS One. 2015; 10(2): e0115538


Knudsen, S. et al.
Development and validation of a gene expression score that predicts response to fulvestrant in breast cancer patients
PLoS One. 2014; 9(2): e87415


Miller, I. et al.
Market access challenges in the EU for high value diagnostic tests
Personalized Medicine. 2011. 8(2): 137-148